CLINICAL_TRIALS
trial_result
· 2010-02-02
Clinical Trial Update: Continue Entecavir Rollover From China [Phase 3]
Summary
A Phase 3 trial of entecavir for chronic hepatitis B has completed, with a rollover from China reported by Bristol-Myers Squibb.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Chronic Hepatitis B Virus | Phase 3 | Status: COMPLETED